Truist Financial cut its price objective on Vericel while TD Cowen boosted its target price.
1 report, 1 independent
Updated 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial cut its price objective on Vericel while TD Cowen boosted its target price.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Vericel
American biopharmaceutical company
Nothing else this week.
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
Related events
- Truist Financial, Citigroup, and TD Cowen updated their price targets for Clean Harbors stock on October 31, 2026.
- Truist Financial set a $90.00 price target on Edwards Lifesciences shares, and TD Cowen reaffirmed its buy rating and raised the price objective.
- Truist Financial boosted its price objective on Match Group stock.
- Analyst firms including TD Cowen, Susquehanna, and Truist Financial raised price targets and provided consensus ratings for AerCap on July 8, 2026.
- Truist Financial set a price objective on Trex Company, Inc. shares.